The Indian Medical Parliamentarians’ Forum (IMPF), a cross-party collective of 45 medical professionals turned ...
To the research team working to save him, KJ Muldoon was first known only as Patient Eta. But within months, KJ’s name — and ...
Researchers discovered that a tiny structural feature of the enzyme GPX4 helps keep neurons safe. A rare mutation removes ...
Sanofi will not be pursuing approval of tolebrutinib for PPMS, and an FDA decision on the therapy in nonrelapsing SPMS will ...
Scientists have identified a small flaw in the enzyme GPX4 that prevents neurons from defending themselves. This mutation, ...
University of California San Diego researchers have discovered the enzyme responsible for chromothripsis, a process in which ...
Hormone therapy can affect collagen, hydration, and breakouts during menopause. Dermatologists explain the real skin benefits ...
The FDA approves the first gene therapy for a rare immune disorder, a landmark decision for genetic medicine, treatment ...
With the black box warning a thing of the past, interest in these once-controversial medications is growing, say experts.
News Medical on MSN
Researchers discover the enzyme responsible for chromothripsis in cancer
University of California San Diego researchers have discovered the enzyme responsible for chromothripsis, a process in which a single chromosome is shattered into pieces and rearranged in a scrambled ...
It is widely known that Alzheimer's disease is mainly associated with the overproduction of β-amyloid peptides and damage ...
Lynk received the green light from the FDA to begin clinical trials of its investigational oral therapy LNK01006 for MS and other diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results